Search

Your search keyword '"Anti cd19"' showing total 4 results
Start Over Descriptor "Anti cd19" Journal annals of oncology
4 results on '"Anti cd19"'

1. ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)

Author

William G. Wierda, Lynn Navale, Adrian Bot, T. Hagenbeek, John M. Rossi, M. José Kersten, Nicola Gökbuget, Gary J. Schiller, Jeffrey S. Wiezorek, Yizhou Jiang, Shanna Stout, Rajul K. Jain, Jeff Aycock, Bijal D. Shah, and Januario E. Castro

Subjects
0301 basic medicine, Oncology, medicine.medical_specialty, Adult patients, business.industry, Lymphoblastic Leukemia, Anti cd19, Hematology, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Multi center study, Relapsed refractory, medicine, Car t cells, business
Published
2016
Full Text
View/download PDF

2. Ongoing complete remissions in phase 1 of ZUMA-1: a phase 1-2 multi-center study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in patients with refractory aggressive B cell non-Hodgkin lymphoma (NHL)

Author

Nancy L. Bartlett, Julio C. Chavez, S.S. Neelapu, William Y. Go, Jeff Aycock, Tanya Siddiqi, M. Sherman, Lynn Navale, Amanda F. Cashen, John M. Rossi, Meg Elias, Jeffrey S. Wiezorek, Frederick L. Locke, Yizhou Jiang, Lihua E. Budde, and Chitra Hosing

Subjects
Oncology, medicine.medical_specialty, business.industry, Anti cd19, Hematology, 03 medical and health sciences, 0302 clinical medicine, Refractory, 030220 oncology & carcinogenesis, Multi center study, Internal medicine, medicine, B-Cell Non-Hodgkin Lymphoma, In patient, Car t cells, business, 030215 immunology
Published
2016
Full Text
View/download PDF

3. ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)

Author

William Y. Go, Thomas J. Kipps, Frederick L. Locke, Yizhou Jiang, Michael Y. Choi, Richard E. Champlin, Michael Wang, Meg Elias, Claudio Anasetti, Hyun-Sung Lee, Stephen J. Forman, Januario E. Castro, John M. Rossi, Jeffrey S. Wiezorek, Tanya Siddiqi, Jeff Aycock, Lynn Navale, Adrian Bot, Lihua E. Budde, and Bijal D. Shah

Subjects
0301 basic medicine, business.industry, Anti cd19, Hematology, medicine.disease, 03 medical and health sciences, 030104 developmental biology, Oncology, Multi center study, Relapsed refractory, Cancer research, Medicine, Mantle cell lymphoma, In patient, Car t cells, business
Published
2016
Full Text
View/download PDF

4. ZUMA-1: A phase 2 multi-center study evaluating anti-CD19 chimeric antigen receptor (CAR) T cells in patients with refractory aggressive non-Hodgkin lymphoma (NHL)

Author

Lazaros J. Lekakis, Olalekan O. Oluwole, Patrick J. Stiff, Januario E. Castro, William Y. Go, Umar Farooq, Lynn Navale, Jeffrey S. Wiezorek, David B. Miklos, Patrick M. Reagan, Caron A. Jacobson, Meg Elias, Nancy L. Bartlett, Frederick L. Locke, Tanya Siddiqi, Ira Braunschweig, Sattva S. Neelapu, Andre Goy, Ian W. Flinn, and John M. Timmerman

Subjects
Oncology, Refractory, business.industry, Multi center study, Anti cd19, Cancer research, Medicine, In patient, Hematology, Aggressive Non-Hodgkin Lymphoma, Car t cells, business, Chimeric antigen receptor
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results